EvelynLFlemingMDFACOG, FACS
Obstetrics & Gynecology • Bedford, NHGynecologic Oncology, Hospice & Palliative Medicine
Assistant Professor, Obstetrics & Gynecology, Geisel School of Medicine
Dr. Fleming is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
5 Washington Pl
Bedford, NH 03110- Is this information wrong?
Summary
- Dr. Evelyn Fleming is a gynecologic oncologist in Lebanon, NH and is affiliated with multiple hospitals in the area, including Cheshire Medical Center, Dartmouth-Hitchcock Medical Center, and the Catholic Medical Center. She received her medical degree from Dartmouth Medical School and has been in practice 16 years. She specializes in gynecologic oncology and hospice & palliative medicine.
Education & Training
Brigham and Women’s HospitalFellowship, Gynecologic Oncology, 2005 - 2008
Women and Infants Hospital of Rhode Island/Brown UniversityResidency, Obstetrics and Gynecology, 2001 - 2005
Geisel School of Medicine at DartmouthClass of 2001
Certifications & Licensure
MT State Medical License 2023 - 2025
VT State Medical License 2022 - 2024
NH State Medical License 2008 - 2024
WY State Medical License 2023 - 2024
MA State Medical License 2006 - 2009
RI State Medical License 2004 - 2005- American Board of Internal Medicine Hospice and Palliative Medicine
- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- Top Doctor, NH magazine 2017-2020
- Top doctor NH magazine, 2017-2018
- National Faculty Award for excellence in residency teaching The council on resident education in obstetrics and gynecology, 2014
- Join now to see all
Clinical Trials
- A Study of VB-111 With Paclitaxel vs Paclitaxel for Treatment of Recurrent Platinum-Resistant Ovarian Cancer (OVAL) Start of enrollment: 2017 Dec 19
- Ribociclib and Letrozole Treatment in Ovarian Cancer Start of enrollment: 2018 Dec 14
Publications & Presentations
PubMed
- 19 citationsOVARIO phase II trial of combination niraparib plus bevacizumab maintenance therapy in advanced ovarian cancer following first-line platinum-based chemotherapy with be...Melissa M Hardesty, Thomas C Krivak, Gail S Wright, Erika Hamilton, Evelyn L Fleming, Jimmy Belotte, Erika K Keeton, Ping Wang, Divya Gupta, Aine Clements, Heidi J Gra...> ;Gynecologic Oncology. 2022 Aug 1
- 69 citationsPhase II study of Vigil® DNA engineered immunotherapy as maintenance in advanced stage ovarian cancer.Jonathan Oh, Minal A. Barve, Carolyn M. Matthews, E. Colin Koon, Thomas P. Heffernan, Bruce Fine, Elizabeth A. Grosen, Melanie K. Bergman, Evelyn Fleming, Leslie R. De...> ;Gynecologic Oncology. 2016 Dec 1
- 34 citationsThe evolving role of hysterectomy in gestational trophoblastic neoplasia at the New England Trophoblastic Disease Center.Evelyn L Fleming, Leslie A. Garrett, Whitfield B. Growdon, Michael J. Callahan, Nicole Suzanne Nevadunsky, Sue Ghosh, Donald P. Goldstein, Ross S. Berkowitz> ;The Journal of Reproductive Medicine. 2008 Jul 1
- Join now to see all
Press Mentions
5 Facts You Should Know About Gynecological CancersSeptember 30th, 2020
The AMA Does Not Speak for UsDecember 9th, 2016
Professional Memberships
- Fellow
- Fellow
Hospital Affiliations
- Cheshire Medical CenterKeene, New Hampshire
Dartmouth-Hitchcock Medical CenterLebanon, New Hampshire
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
